Calif. should not rush to pass biosimilars bill

10/10/2013 | San Francisco Chronicle (free content)

California Gov. Jerry Brown should veto a state law that would limit the use of biosimilars because it is more about protecting profits rather than patients, according to this editorial. The state should not rush to pass SB 598 and wait for the FDA to do its work as standards for safely substituting biosimilars could be laid out early in 2014.

View Full Article in:

San Francisco Chronicle (free content)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA